These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of rate control versus rhythm control for management of atrial fibrillation in patients with coexisting heart failure: a cost-effectiveness analysis. Perez A, Touchette DR, DiDomenico RJ, Stamos TD, Walton SM. Pharmacotherapy; 2011 Jun; 31(6):552-65. PubMed ID: 21923439 [Abstract] [Full Text] [Related]
11. Atrial fibrillation and congestive heart failure: a cost analysis of rhythm-control vs. rate-control strategies. Poulin F, Khairy P, Roy D, Levesque S, Talajic M, Guertin JR, Lelorier J, Atrial Fibrillation and Congestive Heart Failure Trial Investigators. Can J Cardiol; 2013 Oct; 29(10):1256-62. PubMed ID: 23751149 [Abstract] [Full Text] [Related]
12. [Clinical characteristics of patients with persistent atrial fibrillation referred for cardioversion: Spanish Cardioversion Registry (REVERSE)]. Alegret JM, Viñolas X, Sagristá J, Hernández-Madrid A, Berruezo A, Moya A, Martínez Sande JL, Pastor A, nombre de los investigadores del Estudio REVERSE. Rev Esp Cardiol; 2008 Jun; 61(6):630-4. PubMed ID: 18570785 [Abstract] [Full Text] [Related]
19. Influence of the randomized trials, AFFIRM and RACE, on the management of atrial fibrillation in two University Medical Centers. Mason PK, Wood MA, Lake D, Dimarco JP. Am J Cardiol; 2005 May 15; 95(10):1248-50. PubMed ID: 15878004 [Abstract] [Full Text] [Related]
20. Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study. Hagens VE, Rienstra M, Van Veldhuisen DJ, Crijns HJ, Van Gelder IC. Am J Cardiol; 2006 Oct 01; 98(7):929-32. PubMed ID: 16996876 [Abstract] [Full Text] [Related] Page: [Next] [New Search]